About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalJan 10, 2025 · 7:07am ET

IVVDInvivyd, Inc.

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ Against SARS-CoV-2 Variant XEC

Company disclosed the results on January 10, 2025.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+80.0%

RVOL

0.9x

Max high

$0.88

Fuel

3m

Regulatory and ClinicalJan 10, 2025 · 7:07am ET

IVVDInvivyd, Inc.+80.0%

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ Against SARS-CoV-2 Variant XEC

RVOL

0.9x

Max high

$0.88

Fuel

3m

Regulatory and ClinicalJan 7, 2025 · 7:45pm ET

SILOSilo Pharma, Inc. Common Stock

Silo Pharma Granted US Patent for PTSD Treatment

Company prepares for SPC-15 clinical trial.

Regulatory and ClinicalJan 7, 2025 · 7:45pm ET

SILOSilo Pharma, Inc. Common Stock+200.9%

Silo Pharma Granted US Patent for PTSD Treatment

Regulatory and ClinicalJan 6, 2025 · 7:39pm ET

IMRXImmuneering Corporation Class A Common Stock

Immuneering Corporation Announces Positive Data Updates from Phase 2a Trial of IMM-1-104

Company plans to expand the trial with additional arms.

Regulatory and ClinicalJan 6, 2025 · 7:39pm ET

IMRXImmuneering Corporation Class A Common Stock+134.0%

Immuneering Corporation Announces Positive Data Updates from Phase 2a Trial of IMM-1-104

Regulatory and ClinicalJan 6, 2025 · 6:05pm ET

HOTHRocket One Inc.

Hoth Therapeutics Achieves 100% Success in Phase 2a HT-001 Trial for Cancer Treatment Skin Toxicities

100% of patients in Cohort 1 achieved the primary efficacy endpoint.

Regulatory and ClinicalJan 6, 2025 · 6:05pm ET

HOTHRocket One Inc.+386.7%

Hoth Therapeutics Achieves 100% Success in Phase 2a HT-001 Trial for Cancer Treatment Skin Toxicities

Regulatory and ClinicalJan 6, 2025 · 12:25pm ET

FEEDENvue Medical, Inc. Common Stock

NanoVibronix Completes Pilot Phase of UroShield Clinical Study at University of Michigan

Company moves forward with next steps in clinical evaluation.

Regulatory and ClinicalJan 6, 2025 · 12:25pm ET

FEEDENvue Medical, Inc. Common Stock+111.7%

NanoVibronix Completes Pilot Phase of UroShield Clinical Study at University of Michigan

Regulatory and ClinicalJul 22, 2024 · 3:59pm ET

ADILAdial Pharmaceuticals, Inc

Adial Pharmaceuticals Advances to Second Cohort in AD04 Pharmacokinetics Study

Progression in the clinical trial for Alcohol Use Disorder treatment.

Regulatory and ClinicalJul 22, 2024 · 3:59pm ET

ADILAdial Pharmaceuticals, Inc+175.2%

Adial Pharmaceuticals Advances to Second Cohort in AD04 Pharmacokinetics Study

Regulatory and ClinicalApr 9, 2024 · 6:55pm ET

ADILAdial Pharmaceuticals, Inc

Adial Pharmaceuticals Announces Publication of Positive AD04 Trial Data

Company highlights safety and compliance in Alcohol Use Disorder treatment study.

Regulatory and ClinicalApr 9, 2024 · 6:55pm ET

ADILAdial Pharmaceuticals, Inc+149.1%

Adial Pharmaceuticals Announces Publication of Positive AD04 Trial Data

1
…
23
24

Next →

RVOL

10.0x

Max high

$50.55

Fuel

1h 51m

RVOL

15.7x

Max high

$5.64

Fuel

1h 3m

RVOL

9.2x

Max high

$3.80

Fuel

2h 20m

RVOL

2.9x

Max high

$13.97

Fuel

58m

RVOL

1.7x

Max high

$75.00

Fuel

2h 2m

RVOL

2.0x

Max high

$68.50

Fuel

1h 35m